Solid Tumors Clinical Trials in Duarte, California

4 studies are recruiting for solid tumors in Duarte, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

    A study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    City of Hope Medical Center, Duarte, California
    Locations
    22 in total
    Run by
    Incyte Corporation

    See if you can join NCT07195916 on ClinicalTrials.gov

  2. A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

    The purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma (PDAC).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Investigative Site US051, Duarte, California
    Locations
    229 in total
    Run by
    Incyte Corporation

    See if you can join NCT07522073 on ClinicalTrials.gov

  3. Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

    The purpose of this study is to establish the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), safety, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of ORIC-114 as a Single Agent or in Combination with Chemotherapy when administered to patients with advanc…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    City of Hope, Duarte, California
    Locations
    42 in total
    Run by
    ORIC Pharmaceuticals

    See if you can join NCT05315700 on ClinicalTrials.gov

  4. A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

    The primary purpose of this study is to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0405 in patients with select advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    City of Hope, Duarte, California
    Locations
    8 in total
    Run by
    Adcentrx Therapeutics

    See if you can join NCT06710379 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.